Director, Global Regulatory Affairs – CMC Biologics @ (November 2018 - March 2022)
Senior Principal Scientist, Drug Product Manufacturing Science and Technology @ (May 2016 - November 2018)
Quality Assessment Lead @ (April 2015 - April 2016)
Acting Team Leader @ (August 2014 - March 2015)
Senior CMC Reviewer and QbD Liaison @ (March 2013 - July 2014)
CMC Reviewer @ (August 2010 - February 2013)
Senior Formulation Scientist @ (May 2006 - August 2010)
Instructor @ (October 2002 - May 2006)
Assistant Professor @ China State Institute of Pharmaceutical Industry (CSIPI) (August 1998 - May 2000)
Daniel Peng Education
UT Health Sciences College of Pharmacy
Postdoctoral Fellow (Industrial Pharmacy)
2000-2002
West China University of Medical Sciences
Doctor of Philosophy (Ph.D.) (Pharmaceutics)
1993-1998
Xi'an Medical University
B.S. (Pharmacy)
1989-1993
Daniel Peng Skills
Quality by Design
Pharmaceutical Industry
FDA
Question based Review (QbR)
Design of Experiments
Artificial Neural Networks
Multivariate Analysis
CMC Regulatory Affairs
Formulation Development
Pharmaceutcial Process Development
Biodegradable polymeric delivery system
Nanoparticles
Compression and compaction
HPLC
Formulation
Pharmaceutics
Chemistry
Validation
Sop
Technology Transfer
Drug Delivery
Analytical Chemistry
GMP
Regulatory Affairs
Biotechnology
Regulatory Submissions
Leadership
Question Based Review Qbr
Process Improvement
Strategic Planning
Program Management
U.S. Food And Drug Administration Fda
Management
Question Based Review
Artificial Neural
Compression
Liaison
CMC
Pharmaceutcial Process
Biodegradable Polymeric
u.s. Food and Drug Administration
Daniel Peng Summary
Daniel Peng, based in Philadelphia, PA, US, is currently a Executive Director, Regulatory Affairs CMC at Insmed Incorporated. Daniel Peng brings experience from previous roles at Checkpoint Therapeutics Inc, Merck and Shire. Daniel Peng holds a 2000 - 2002 Postdoctoral Fellow in Industrial Pharmacy @ UT Health Sciences College of Pharmacy. With a robust skill set that includes Quality by Design, Pharmaceutical Industry, FDA, Question based Review (QbR), Design of Experiments and more. Daniel Peng has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Daniel Peng?
Find contact details for 700 million professionals.